Kbc Group Nv Aqua Bounty Technologies, Inc. Transaction History

Kbc Group Nv

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$2.1 - $4.36 $150,147 - $311,735	-71,499 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$4.85 - $6.9 $190,120 - $270,480	39,200 Added 121.37%	71,499 $383,000
Q1 2021 Apr 26, 2021	SELL	$6.09 - $12.2 $183,309 - $367,220	-30,100 Reduced 48.24%	32,299 $216,000
Q4 2020 Feb 10, 2021	SELL	$3.56 - $10.21 $11,036 - $31,651	-3,100 Reduced 4.73%	62,399 $547,000
Q3 2020 Oct 28, 2020	SELL	$2.49 - $5.16 $22,908 - $47,472	-9,200 Reduced 12.32%	65,499 $293,000
Q2 2020 Aug 10, 2020	BUY	$1.65 - $3.4 $20,295 - $41,820	12,300 Added 19.71%	74,699 $241,000
Q4 2019 Feb 11, 2020	BUY	$2.0 - $2.64 $123,948 - $163,611	61,974 Added 14582.12%	62,399 $135,000
Q3 2019 Nov 07, 2019	SELL	$2.5 - $3.93 $7,687 - $12,084	-3,075 Reduced 87.86%	425 $1,000
Q2 2019 Dec 03, 2019	BUY	$1.96 - $3.21 $6,860 - $11,235	3,500 New	3,500 $11,000
Q2 2019 Jul 30, 2019	SELL	$1.96 - $3.21 $6,860 - $11,235	-3,500 Closed	0 $0
Q1 2019 Dec 03, 2019	BUY	$2.11 - $4.89 $7,385 - $17,115	3,500 New	3,500 $8,000

5.32M

Ticker AQB
Exchange NASDAQ
Sector Consumer Defensive
Industry Farm Products
Shares Outstandng 71,110,704
Market Cap $84.6M
Description
AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sel...

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

Stay updated on Kbc Group Nv with notifications on news.